Does anyone have experience filing investigational drug applications (INDs, CTAs, CTNs) in multiple jurisdictions simultaneously to perform a global clinical trial? If so, what are the procedural considerations, and are there any collaborative pathways between ICH regulators to streamline the review and approval of multijurisdictional trial applications?
------------------------------
Marshall Hoke
Director of Regulatory Affairs
Lafayette CO
United States
------------------------------